Snail secretion study points to new mastitis research avenue
Researchers at the University of Messina reported that snail secretion filtrate, or SSF, reduced inflammatory and oxidative-stress markers in an in vitro model of bovine mastitis, adding another early data point to the search for non-antibiotic supportive approaches in dairy cattle. In the Veterinary Record Open study, published February 15, 2026, the team exposed MAC-T bovine mammary epithelial cells to lipopolysaccharide and found that SSF from Helix aspersa Muller lowered reactive oxygen species, malondialdehyde, nitric oxide, prostaglandin E2, and pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β, while helping preserve glutathione levels. The paper describes SSF as a mechanically collected, filtered product supplied by Snail S.r.l., and the authors say the findings support further study of SSF as a natural, sustainable mastitis intervention. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals, the study fits into a broader push to find mastitis tools that could complement, reduce, or better target antimicrobial use, especially because not all clinical mastitis cases benefit from antibiotics and inflammation itself drives tissue damage, pain, and milk loss. Still, this is a cell-culture study, not an animal trial, and the paper does not show bacteriologic cure, clinical outcomes, residue data, dosing protocols, or on-farm feasibility. That means SSF is best viewed as an early-stage candidate with biologic plausibility, not a practice-ready therapy. (pmc.ncbi.nlm.nih.gov)
What to watch: The next meaningful step will be whether the group, or others, moves SSF into controlled in vivo mastitis studies that can test safety, efficacy, milk-withdrawal implications, and how it might fit alongside established treatment protocols. (pmc.ncbi.nlm.nih.gov)